EGFR and central nervous system cancer: While the presence of FIG‐ROS in glioma has been seen in only two tumor‐derived cell lines to date, overexpression of the native ROS kinase does occur somewhat more frequently in actual tumors (∼30% of cases) and activates similar signaling cascades to those directed by EGFR and PDGFR (91).